U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018271) titled 'A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients' on May 27.
Brief Summary: The goal of this study is to observe and evaluate the incidence of infection in newly diagnosed, non-transplanted multiple myeloma patients receiving prophylactic treatment with sulpegfilgrastim (a pegylated recombinant human granulocyte colony-stimulating factor).
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Multiple Myeloma
DRD
Sulpegfilgrastim
Neutropenia
Intervention:
DRUG: sulpegfilgrastim
On Day 1 of each oncological treatm...